Rchr
J-GLOBAL ID：202401001453144030
Update date: May. 26, 2025
Senpuku Kota
センプク コウタ | Senpuku Kota
Research theme for competitive and other funds (1)：
- 2022 - 2025 次世代研究者挑戦的研究プログラム
Papers (5)：
-
Kota Senpuku, Yuta Kunishima, Kotaro Taniguchi, Taiki Ito, Toshiro Hirai, Teruya Nakamura, Chikako Kataoka-Nakamura, Yasuo Yoshioka. Development and characterization of MRC-5 and Vero cell-adapted enterovirus D68 strains for vaccine production. Vaccine. 2025. 60. 127314-127314
-
Atsushi Kawai, Taro Shimizu, Hiroki Tanaka, Shintaro Shichinohe, Jessica Anindita, Mika Hirose, Eigo Kawahara, Kota Senpuku, Makoto Shimooka, Le Thi Quynh Mai, et al. Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions. Molecular Therapy. 2024
-
Eigo Kawahara, Kota Senpuku, Yoshino Kawaguchi, Shinya Yamamoto, Koubun Yasuda, Etsushi Kuroda, Noriko Ouji-Sageshima, Toshihiro Ito, Toshiro Hirai, Takehiko Shibata, et al. Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction. npj Vaccines. 2024. 9. 1
-
Kota Senpuku, Chikako Kataoka-Nakamura, Yuta Kunishima, Toshiro Hirai, Yasuo Yoshioka. An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice. Vaccine. 2024. 42. 9. 2463-2474
-
Junsuke Hayashi, Yosuke Ochi, Kota Senpuku, Shun-ichi Wada, Fumito Wada, Mariko Harada-Shiba, Hidehito Urata. Rational design of prodrug-type apoB-targeted siRNA for nuclease resistance improvement without compromising gene silencing potency. Bioorganic & Medicinal Chemistry. 2024. 104. 117693-117693
Education (1)：
- 2021 - 2025 The University of Osaka Graduate School of Pharmaceutical Sciences Medical Pharmacy
Professional career (1)：
Awards (3)：
- 2024/05 - 日本薬剤学会第39年会 最優秀発表者賞
- 2023/10 - 第27回日本ワクチン学会・第64回日本臨床ウイルス学会 合同学術集会 若手奨励最優秀賞
- 2023/05 - 日本薬剤学会第38年会 SNPEE 2023 Presentation Award
Return to Previous Page
